Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.

Aletaha, Daniel

Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints. [electronic resource] - Arthritis and rheumatism Dec 2011 - 3702-11 p. digital

Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't

1529-0131

10.1002/art.30634 doi


Adalimumab
Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized--therapeutic use
Antirheumatic Agents--therapeutic use
Arthritis, Rheumatoid--drug therapy
Arthrography
Disease Progression
Dose-Response Relationship, Drug
Drug Therapy, Combination
Female
Humans
Infliximab
Joints--pathology
Male
Methotrexate--therapeutic use
Middle Aged
Outcome Assessment, Health Care--methods
Remission Induction
Retrospective Studies
Severity of Illness Index
Treatment Outcome
Young Adult